EarningsScore
SE · Healthcare / Medical Devices · Q3 2026 · 2026-10-23
Boule Diagnostics
"Management tone is deeply negative, reflecting a company in operational and financial distress. The CEO acknowledges results were 'significantly weaker than expected,' component shortages are unresolved, demand is weak across key segments, and the board is evaluating financing options under a going-concern assumption."
Full analysis — hedging frequency, guidance certainty,
trend chart and 8-quarter history
Create free account →